Who makes sIPV batch 2?

sIPV batch 2 is developed by Institute of Medical Biology, Chinese Academy of Medical Sciences.

What development phase is sIPV batch 2 in?

sIPV batch 2 is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

sIPV batch 2

Institute of Medical Biology, Chinese Academy of Medical Sciences · FDA-approved active Biologic Quality 2/100

At a glance

Generic name	sIPV batch 2
Sponsor	Institute of Medical Biology, Chinese Academy of Medical Sciences
Modality	Biologic
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Consistency Study for Three Commercial Lots of Inactivated Poliomyelitis Vaccine Made From Sabin Strain (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

sIPV batch 2 CI brief — competitive landscape report
sIPV batch 2 updates RSS · CI watch RSS
Institute of Medical Biology, Chinese Academy of Medical Sciences portfolio CI